Immune Checkpoint Agents Market - Global Outlook and Forecast 2021-2027

Code: RW00014557273
Market Monitor Global
Oct-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Immune Checkpoint Agents in global, including the following market information:
Global Immune Checkpoint Agents Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Immune Checkpoint Agents Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Immune Checkpoint Agents companies in 2020 (%)
The global Immune Checkpoint Agents market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Checkpoint Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Checkpoint Agents Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Immune Checkpoint Agents Market Segment Percentages, By Type, 2020 (%)
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4

Global Immune Checkpoint Agents Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Immune Checkpoint Agents Market Segment Percentages, By Application, 2020 (%)
Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers

Global Immune Checkpoint Agents Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Immune Checkpoint Agents Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Checkpoint Agents revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Immune Checkpoint Agents revenues share in global market, 2020 (%)
Key companies Immune Checkpoint Agents sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Immune Checkpoint Agents sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Merck
AstraZeneca
Roche

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Immune Checkpoint Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Checkpoint Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Checkpoint Agents Overall Market Size
2.1 Global Immune Checkpoint Agents Market Size: 2021 VS 2027
2.2 Global Immune Checkpoint Agents Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Immune Checkpoint Agents Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Immune Checkpoint Agents Players in Global Market
3.2 Top Global Immune Checkpoint Agents Companies Ranked by Revenue
3.3 Global Immune Checkpoint Agents Revenue by Companies
3.4 Global Immune Checkpoint Agents Sales by Companies
3.5 Global Immune Checkpoint Agents Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Immune Checkpoint Agents Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Immune Checkpoint Agents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Checkpoint Agents Players in Global Market
3.8.1 List of Global Tier 1 Immune Checkpoint Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune Checkpoint Agents Market Size Markets, 2021 & 2027
4.1.2 Anti-PD-L1 Drug
4.1.3 Anti-PD-1 Drug
4.1.4 CTLA4
4.2 By Type - Global Immune Checkpoint Agents Revenue & Forecasts
4.2.1 By Type - Global Immune Checkpoint Agents Revenue, 2016-2021
4.2.2 By Type - Global Immune Checkpoint Agents Revenue, 2022-2027
4.2.3 By Type - Global Immune Checkpoint Agents Revenue Market Share, 2016-2027
4.3 By Type - Global Immune Checkpoint Agents Sales & Forecasts
4.3.1 By Type - Global Immune Checkpoint Agents Sales, 2016-2021
4.3.2 By Type - Global Immune Checkpoint Agents Sales, 2022-2027
4.3.3 By Type - Global Immune Checkpoint Agents Sales Market Share, 2016-2027
4.4 By Type - Global Immune Checkpoint Agents Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Checkpoint Agents Market Size, 2021 & 2027
5.1.2 Lung Cancer
5.1.3 Colorectal Cancer
5.1.4 BreastCancer
5.1.5 Prostate Cancer
5.1.6 Melanoma
5.1.7 Blood Cancers
5.2 By Application - Global Immune Checkpoint Agents Revenue & Forecasts
5.2.1 By Application - Global Immune Checkpoint Agents Revenue, 2016-2021
5.2.2 By Application - Global Immune Checkpoint Agents Revenue, 2022-2027
5.2.3 By Application - Global Immune Checkpoint Agents Revenue Market Share, 2016-2027
5.3 By Application - Global Immune Checkpoint Agents Sales & Forecasts
5.3.1 By Application - Global Immune Checkpoint Agents Sales, 2016-2021
5.3.2 By Application - Global Immune Checkpoint Agents Sales, 2022-2027
5.3.3 By Application - Global Immune Checkpoint Agents Sales Market Share, 2016-2027
5.4 By Application - Global Immune Checkpoint Agents Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Immune Checkpoint Agents Market Size, 2021 & 2027
6.2 By Region - Global Immune Checkpoint Agents Revenue & Forecasts
6.2.1 By Region - Global Immune Checkpoint Agents Revenue, 2016-2021
6.2.2 By Region - Global Immune Checkpoint Agents Revenue, 2022-2027
6.2.3 By Region - Global Immune Checkpoint Agents Revenue Market Share, 2016-2027
6.3 By Region - Global Immune Checkpoint Agents Sales & Forecasts
6.3.1 By Region - Global Immune Checkpoint Agents Sales, 2016-2021
6.3.2 By Region - Global Immune Checkpoint Agents Sales, 2022-2027
6.3.3 By Region - Global Immune Checkpoint Agents Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Immune Checkpoint Agents Revenue, 2016-2027
6.4.2 By Country - North America Immune Checkpoint Agents Sales, 2016-2027
6.4.3 US Immune Checkpoint Agents Market Size, 2016-2027
6.4.4 Canada Immune Checkpoint Agents Market Size, 2016-2027
6.4.5 Mexico Immune Checkpoint Agents Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Immune Checkpoint Agents Revenue, 2016-2027
6.5.2 By Country - Europe Immune Checkpoint Agents Sales, 2016-2027
6.5.3 Germany Immune Checkpoint Agents Market Size, 2016-2027
6.5.4 France Immune Checkpoint Agents Market Size, 2016-2027
6.5.5 U.K. Immune Checkpoint Agents Market Size, 2016-2027
6.5.6 Italy Immune Checkpoint Agents Market Size, 2016-2027
6.5.7 Russia Immune Checkpoint Agents Market Size, 2016-2027
6.5.8 Nordic Countries Immune Checkpoint Agents Market Size, 2016-2027
6.5.9 Benelux Immune Checkpoint Agents Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Immune Checkpoint Agents Revenue, 2016-2027
6.6.2 By Region - Asia Immune Checkpoint Agents Sales, 2016-2027
6.6.3 China Immune Checkpoint Agents Market Size, 2016-2027
6.6.4 Japan Immune Checkpoint Agents Market Size, 2016-2027
6.6.5 South Korea Immune Checkpoint Agents Market Size, 2016-2027
6.6.6 Southeast Asia Immune Checkpoint Agents Market Size, 2016-2027
6.6.7 India Immune Checkpoint Agents Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Immune Checkpoint Agents Revenue, 2016-2027
6.7.2 By Country - South America Immune Checkpoint Agents Sales, 2016-2027
6.7.3 Brazil Immune Checkpoint Agents Market Size, 2016-2027
6.7.4 Argentina Immune Checkpoint Agents Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immune Checkpoint Agents Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Immune Checkpoint Agents Sales, 2016-2027
6.8.3 Turkey Immune Checkpoint Agents Market Size, 2016-2027
6.8.4 Israel Immune Checkpoint Agents Market Size, 2016-2027
6.8.5 Saudi Arabia Immune Checkpoint Agents Market Size, 2016-2027
6.8.6 UAE Immune Checkpoint Agents Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Corporate Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Immune Checkpoint Agents Major Product Offerings
7.1.4 Bristol Myers Squibb Immune Checkpoint Agents Sales and Revenue in Global (2016-2021)
7.1.5 Bristol Myers Squibb Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Immune Checkpoint Agents Major Product Offerings
7.2.4 Merck Immune Checkpoint Agents Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Immune Checkpoint Agents Major Product Offerings
7.3.4 AstraZeneca Immune Checkpoint Agents Sales and Revenue in Global (2016-2021)
7.3.5 AstraZeneca Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Immune Checkpoint Agents Major Product Offerings
7.4.4 Roche Immune Checkpoint Agents Sales and Revenue in Global (2016-2021)
7.4.5 Roche Key News
8 Global Immune Checkpoint Agents Production Capacity, Analysis
8.1 Global Immune Checkpoint Agents Production Capacity, 2016-2027
8.2 Immune Checkpoint Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Checkpoint Agents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immune Checkpoint Agents Supply Chain Analysis
10.1 Immune Checkpoint Agents Industry Value Chain
10.2 Immune Checkpoint Agents Upstream Market
10.3 Immune Checkpoint Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Checkpoint Agents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Immune Checkpoint Agents in Global Market
Table 2. Top Immune Checkpoint Agents Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Immune Checkpoint Agents Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Immune Checkpoint Agents Revenue Share by Companies, 2016-2021
Table 5. Global Immune Checkpoint Agents Sales by Companies, (K Units), 2016-2021
Table 6. Global Immune Checkpoint Agents Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Immune Checkpoint Agents Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Immune Checkpoint Agents Product Type
Table 9. List of Global Tier 1 Immune Checkpoint Agents Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Bristol Myers Squibb
Merck
AstraZeneca
Roche

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE